Verna Mai

906 total citations
28 papers, 679 citations indexed

About

Verna Mai is a scholar working on Oncology, Epidemiology and Pathology and Forensic Medicine. According to data from OpenAlex, Verna Mai has authored 28 papers receiving a total of 679 indexed citations (citations by other indexed papers that have themselves been cited), including 25 papers in Oncology, 12 papers in Epidemiology and 4 papers in Pathology and Forensic Medicine. Recurrent topics in Verna Mai's work include Global Cancer Incidence and Screening (21 papers), Colorectal Cancer Screening and Detection (17 papers) and Cervical Cancer and HPV Research (12 papers). Verna Mai is often cited by papers focused on Global Cancer Incidence and Screening (21 papers), Colorectal Cancer Screening and Detection (17 papers) and Cervical Cancer and HPV Research (12 papers). Verna Mai collaborates with scholars based in Canada, United States and United Kingdom. Verna Mai's co-authors include Anna M. Chiarelli, Donna E. Stewart, Anna R. Gagliardi, Lawrence Paszat, Paula C. Barata, Linda Rabeneck, Carlo Senore, Montse García, Jean‐Luc Bulliard and Carrie N. Klabunde and has published in prestigious journals such as SHILAP Revista de lepidopterología, European Journal of Cancer and Preventive Medicine.

In The Last Decade

Verna Mai

28 papers receiving 644 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Verna Mai Canada 17 523 248 132 108 92 28 679
Tytti Sarkeala Finland 16 467 0.9× 146 0.6× 94 0.7× 52 0.5× 60 0.7× 59 652
Mette Bach Larsen Denmark 18 434 0.8× 153 0.6× 138 1.0× 133 1.2× 89 1.0× 57 703
Donald Blackman United States 11 493 0.9× 150 0.6× 196 1.5× 73 0.7× 69 0.8× 13 638
RA Hiatt United States 4 336 0.6× 125 0.5× 71 0.5× 37 0.3× 40 0.4× 5 480
Ciara Smalls Glover United States 6 281 0.5× 140 0.6× 45 0.3× 45 0.4× 37 0.4× 11 523
Gigi Yuan United States 11 543 1.0× 130 0.5× 222 1.7× 84 0.8× 104 1.1× 12 664
Natalie Fitzgerald Canada 11 290 0.6× 102 0.4× 115 0.9× 59 0.5× 29 0.3× 26 618
Carolynn Gildea United Kingdom 12 386 0.7× 108 0.4× 100 0.8× 81 0.8× 30 0.3× 27 583
Teresa Smith United States 10 299 0.6× 161 0.6× 76 0.6× 45 0.4× 33 0.4× 17 515
R. Ancelle-Park France 11 309 0.6× 116 0.5× 88 0.7× 20 0.2× 67 0.7× 20 435

Countries citing papers authored by Verna Mai

Since Specialization
Citations

This map shows the geographic impact of Verna Mai's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Verna Mai with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Verna Mai more than expected).

Fields of papers citing papers by Verna Mai

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Verna Mai. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Verna Mai. The network helps show where Verna Mai may publish in the future.

Co-authorship network of co-authors of Verna Mai

This figure shows the co-authorship network connecting the top 25 collaborators of Verna Mai. A scholar is included among the top collaborators of Verna Mai based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Verna Mai. Verna Mai is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Bulliard, Jean‐Luc, Montse García, Johannes Blom, et al.. (2013). Sorting out measures and definitions of screening participation to improve comparability: The example of colorectal cancer. European Journal of Cancer. 50(2). 434–446. 31 indexed citations
2.
Green, Esther, et al.. (2013). Chronic Disease Prevention and Management: Implications for Health Human Resources in 2020. Healthcare Quarterly. 11(1). 38–43. 6 indexed citations
3.
Schoueri‐Mychasiw, Nour, et al.. (2012). Increasing Screening Mammography Among Immigrant and Minority Women in Canada: A Review of Past Interventions. Journal of Immigrant and Minority Health. 15(1). 149–158. 18 indexed citations
4.
Bryant, Heather & Verna Mai. (2011). Impact of age-specific recommendation changes on organized breast screening programs. Preventive Medicine. 53(3). 141–143. 3 indexed citations
5.
Kaczorowski, Janusz, et al.. (2011). Pay-for-performance incentives for preventive care: views of family physicians before and after participation in a reminder and recall project (P-PROMPT).. PubMed. 57(6). 690–6. 9 indexed citations
6.
Edwards, Sarah, et al.. (2010). Satisfaction With Initial Screen and Compliance With Biennial Breast Screening at Centers With and Without Nurses. Cancer Nursing. 34(4). 293–301. 4 indexed citations
7.
Chiarelli, Anna M., Vicky Majpruz, Patrick Brown, et al.. (2010). Influence of Nurses on Compliance with Breast Screening Recommendations in an Organized Breast Screening Program. Cancer Epidemiology Biomarkers & Prevention. 19(3). 697–706. 9 indexed citations
8.
Howlett, Roberta I., et al.. (2009). Defining a strategy to evaluate cervical cancer prevention and early detection in the era of HPV vaccination. Preventive Medicine. 48(5). 432–437. 11 indexed citations
9.
Mai, Verna, Terrence Sullivan, & Anna M. Chiarelli. (2009). Breast cancer screening program in canada: successes and challenges. Salud Pública de México. 51. s228–s235. 29 indexed citations
10.
Ritvo, Paul, Ronald E. Myers, M. Elisabeth Del Giudice, et al.. (2009). Fecal occult blood testing: people in Ontario are unaware of it and not ready for it.. PubMed. 55(2). 176–177.e4. 10 indexed citations
11.
Rabeneck, Linda, et al.. (2008). Cancer Care Ontario guaiac fecal occult blood test (FOBT) laboratory standards: Evidentiary base and recommendations. Clinical Biochemistry. 41(16-17). 1289–1305. 27 indexed citations
12.
Chiarelli, Anna M., et al.. (2008). Influence of physician and patient characteristics on adherence to breast cancer screening recommendations. European Journal of Cancer Prevention. 17(1). 48–53. 19 indexed citations
13.
Barata, Paula C., et al.. (2008). Discussions about self-obtained samples for HPV testing as an alternative for cervical cancer prevention. Journal of Psychosomatic Obstetrics & Gynecology. 29(4). 251–257. 36 indexed citations
14.
McLachlin, C. Meg, Verna Mai, Joan Murphy, et al.. (2007). Ontario Cervical Cancer Screening Clinical Practice Guidelines. Journal of Obstetrics and Gynaecology Canada. 29(4). 344–353. 16 indexed citations
15.
Stewart, Donna E., Anna R. Gagliardi, Mary Johnston, et al.. (2007). Self-Collected Samples for Testing of Oncogenic Human Papillomavirus: A Systematic Review. Journal of Obstetrics and Gynaecology Canada. 29(10). 817–828. 82 indexed citations
16.
Rakovitch, Eileen, Jean‐Philippe Pignol, Carole Chartier, et al.. (2006). The management of ductal carcinoma in situ of the breast: a screened population-based analysis. Breast Cancer Research and Treatment. 101(3). 335–347. 57 indexed citations
17.
18.
Chiarelli, Anna M., et al.. (2005). Performance measures from 10 years of breast screening in the Ontario Breast Screening Program, 1990/91 to 2000. European Journal of Cancer Prevention. 15(1). 34–42. 35 indexed citations
19.
Stuart, Gavin, Gregory Taylor, Christina Bancej, et al.. (2004). Report of the 2003 Pan-Canadian Forum on Cervical Cancer Prevention and Control. Journal of Obstetrics and Gynaecology Canada. 26(11). 1004–1014. 16 indexed citations
20.
Paszat, Lawrence, et al.. (2003). Socioeconomic status & returning for a second screen in the Ontario breast screening program. The Breast. 12(4). 237–246. 35 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Tytti Sarkeala Breakdown of academic impact, for papers by Mette Bach Larsen Breakdown of academic impact, for papers by Donald Blackman Breakdown of academic impact, for papers by RA Hiatt Breakdown of academic impact, for papers by Ciara Smalls Glover Breakdown of academic impact, for papers by Gigi Yuan Breakdown of academic impact, for papers by Natalie Fitzgerald Breakdown of academic impact, for papers by Carolynn Gildea Breakdown of academic impact, for papers by Teresa Smith Breakdown of academic impact, for papers by R. Ancelle-Park
Rankless by CCL
2026